These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 9618443)

  • 1. Nontypeable Haemophilus influenzae: pathogenesis and prevention.
    Foxwell AR; Kyd JM; Cripps AW
    Microbiol Mol Biol Rev; 1998 Jun; 62(2):294-308. PubMed ID: 9618443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.
    Winter LE; Barenkamp SJ
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models.
    Hong W; Peng D; Rivera M; Gu XX
    Microbes Infect; 2010 Jan; 12(1):11-8. PubMed ID: 19782149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge.
    Kennedy BJ; Novotny LA; Jurcisek JA; Lobet Y; Bakaletz LO
    Infect Immun; 2000 May; 68(5):2756-65. PubMed ID: 10768970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media.
    Hong W; Mason K; Jurcisek J; Novotny L; Bakaletz LO; Swords WE
    Infect Immun; 2007 Feb; 75(2):958-65. PubMed ID: 17130253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx.
    Kyd JM; Cripps AW; Novotny LA; Bakaletz LO
    Infect Immun; 2003 Aug; 71(8):4691-9. PubMed ID: 12874350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine.
    Poolman JT; Bakaletz L; Cripps A; Denoel PA; Forsgren A; Kyd J; Lobet Y
    Vaccine; 2000 Dec; 19 Suppl 1():S108-15. PubMed ID: 11163473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen.
    Duell BL; Su YC; Riesbeck K
    FEBS Lett; 2016 Nov; 590(21):3840-3853. PubMed ID: 27508518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling Haemophilus influenzae virulence mechanisms enable discovery of new targets for antimicrobials and vaccines.
    Langereis JD; de Jonge MI
    Curr Opin Infect Dis; 2020 Jun; 33(3):231-237. PubMed ID: 32304471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
    Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae.
    Whitby PW; Morton DJ; Mussa HJ; Mirea L; Stull TL
    Vaccine; 2020 Mar; 38(14):2960-2970. PubMed ID: 32111525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media.
    Langereis JD; Stol K; Schweda EK; Twelkmeyer B; Bootsma HJ; de Vries SP; Burghout P; Diavatopoulos DA; Hermans PW
    mBio; 2012; 3(4):e00079-12. PubMed ID: 22761391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why we need a vaccine for non-typeable Haemophilus influenzae.
    Cerquetti M; Giufrè M
    Hum Vaccin Immunother; 2016 Sep; 12(9):2357-61. PubMed ID: 27171854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
    Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
    Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic Acid Protects Nontypeable Haemophilus influenzae from Natural IgM and Promotes Survival in Murine Respiratory Tract.
    Jackson MD; Wong SM; Akerley BJ
    Infect Immun; 2021 May; 89(6):. PubMed ID: 33782153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media.
    DeMaria TF; Murwin DM; Leake ER
    Infect Immun; 1996 Dec; 64(12):5187-92. PubMed ID: 8945564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274.
    Ueyama T; Gu XX; Tsai CM; Karpas AB; Lim DJ
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):96-100. PubMed ID: 9874671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress toward molecular determinants of the pathogenesis of disease due to nontypeable Haemophilus influenzae].
    Tian GZ; Zhang L; Shao ZJ
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):174-9. PubMed ID: 20077666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model.
    Sun J; Chen J; Cheng Z; Robbins JB; Battey JF; Gu XX
    Vaccine; 2000 Jan; 18(13):1264-72. PubMed ID: 10649628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.
    Khan MN; Ren D; Kaur R; Basha S; Zagursky R; Pichichero ME
    Expert Rev Vaccines; 2016 Jul; 15(7):863-78. PubMed ID: 26894630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.